SI2272868T1 - Kombinirana terapija za B-celične motnje - Google Patents

Kombinirana terapija za B-celične motnje

Info

Publication number
SI2272868T1
SI2272868T1 SI200432245T SI200432245T SI2272868T1 SI 2272868 T1 SI2272868 T1 SI 2272868T1 SI 200432245 T SI200432245 T SI 200432245T SI 200432245 T SI200432245 T SI 200432245T SI 2272868 T1 SI2272868 T1 SI 2272868T1
Authority
SI
Slovenia
Prior art keywords
combination therapy
cell disorders
disorders
cell
therapy
Prior art date
Application number
SI200432245T
Other languages
English (en)
Inventor
Andrew Chan
Qian Gong
Flavius Martin
Original Assignee
Genentech, Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc., filed Critical Genentech, Inc.,
Priority claimed from EP10009416.8A external-priority patent/EP2272868B1/en
Publication of SI2272868T1 publication Critical patent/SI2272868T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SI200432245T 2003-06-05 2004-06-04 Kombinirana terapija za B-celične motnje SI2272868T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47641403P 2003-06-05 2003-06-05
US47648103P 2003-06-05 2003-06-05
US47653103P 2003-06-06 2003-06-06
EP10009416.8A EP2272868B1 (en) 2003-06-05 2004-06-04 Combination therapy for B cell disorders

Publications (1)

Publication Number Publication Date
SI2272868T1 true SI2272868T1 (sl) 2015-07-31

Family

ID=37003283

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200432241T SI1631313T1 (sl) 2003-06-05 2004-06-04 Kombinirana terapija za B-celične motnje
SI200432245T SI2272868T1 (sl) 2003-06-05 2004-06-04 Kombinirana terapija za B-celične motnje

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SI200432241T SI1631313T1 (sl) 2003-06-05 2004-06-04 Kombinirana terapija za B-celične motnje

Country Status (3)

Country Link
CN (1) CN1835972A (sl)
DK (1) DK2272868T3 (sl)
SI (2) SI1631313T1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101851278B (zh) 2010-05-26 2013-03-13 石药集团中奇制药技术（石家庄）有限公司 B细胞激活因子拮抗剂及其制备方法与用途
EP2680884B1 (en) * 2011-02-28 2018-01-17 F. Hoffmann-La Roche AG Biological markers and methods for predicting response to b-cell antagonists
CN103596590A (zh) * 2011-04-01 2014-02-19 伊缪诺金公司 Cd37结合分子及其免疫缀合物
CN103936833B (zh) * 2014-04-18 2016-02-10 天津大学 BLyS拮抗肽、含TC-Fc融合蛋白基因的质粒及TC-Fc融合蛋白
CN113136365A (zh) * 2021-04-29 2021-07-20 中山大学附属口腔医院 基于组蛋白去乙酰化酶抑制活性诱导调节性b细胞高效扩增的试剂及其应用

Also Published As

Publication number Publication date
DK2272868T3 (en) 2015-06-15
SI1631313T1 (sl) 2015-06-30
CN1835972A (zh) 2006-09-20

Similar Documents

Publication Publication Date Title
PL1631313T3 (pl) Terapia skojarzona zaburzeń z komórek B
AU2003259152A8 (en) Cell therapy for regeneration
AU2003282679A8 (en) Hydroxypyrazoles for use against metabolic-related disorders
GB0307918D0 (en) Therapeutic use
IL177155A0 (en) Therapeutic combinations
GB0218526D0 (en) Combination therapy
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
GB0323258D0 (en) Therapeutic compounds
GB0300586D0 (en) Therapeutic microfoam
GB0424339D0 (en) Combination therapy
GB0328588D0 (en) Collimator
SI2272868T1 (sl) Kombinirana terapija za B-celične motnje
GB0417558D0 (en) Novel combination therapy
GB0303289D0 (en) Combination therapy
AU2003231937A8 (en) Therapeutic methods
GB0325021D0 (en) Therapeutic combinations
GB0421436D0 (en) Combination therapy
GB0421438D0 (en) Combination therapy
GB0213383D0 (en) Therapeutic conditions
GB0307560D0 (en) Combination therapy
GB0318311D0 (en) Combination therapy
GB0314097D0 (en) Combination therapy
GB0316176D0 (en) Combination therapy
GB0316184D0 (en) Combination therapy